Approx 100M shares on offer if you include outstanding options. (very rough estimate)
$3 equates to a AUD$300M market cap. Far too cheap in my opinion.
When you look at recent acquisitions and the entire regenerative medicine space I'd be think a USD$500M+ (AUD$615M or $6.15 a share) is more likely. I'd expect nothing less to be quite honest.
The tech can be licensed across many multiples of disease targets and modified MSC approaches. That's a very BIG market.
Approx 100M shares on offer if you include outstanding options....
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.015(7.32%) |
Mkt cap ! $34.30M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 19.0¢ | $6.137K | 32.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5047 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 10.02am 03/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |